Artios Pharma has announced the appointment of Professor Rajesh Chopra as non-executive director.
Throughout his exceptional career in Pharmaceutical R&D, Professor Chopra has held a number of distinguished roles including corporate vice president of Translational Research at Celgene, where he led US and European teams of scientists in San Diego, San Francisco and Seville, and clinicians involved in taking agents from discovery to proof-of-concept clinical trials in oncology and immune/inflammatory diseases, as well as in stem cell therapies.
He is an experienced scientist and clinical leader who has discovered and developed a number of novel cancer treatments, across different technologies such as small molecules, biologics and gene therapy, and trained in Medicine at University College London where he also got his PhD in Medicine, Cell and Molecular Biology.
